Close on 09 Oct 2026
All Indian Equities

FORTIS HEALTHCARE

FORTISVerified
ISIN: BSE:532843 · Exchange: NSE/BSE

FORTIS HEALTHCARE is a publicly traded security listed on the NSE/BSE exchange.

Sector: Diversified Indian Equities·Industry: Public Market Listed Security·Market Cap: LARGE CAP
Close on 09 Oct 2026
₹786.25
+23.25 (+3.05%)
Last updated: 09 Oct 2026 (NSE/BSE EOD settlement)

Stock Snapshot & Key Numbers — FORTIS HEALTHCARE

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Up +3.05% on 09 Oct 2026
Position vs 1-Year High
28.4% below 52W High
P/E Valuation Multiple
56.6x (Above 40x)
Annual Cash Dividend
0.13% Dividend Yield
Close on 09 Oct 2026
₹786.25
+23.25 (+3.05%)vs prev close
1-Year Low to High Range7% of range
Low: ₹763High: ₹1,098
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):56.6x
P/B Ratio (Price / Book):6.0x
Dividend Yield:0.13%
Total Company Value (Market Cap)
₹59,358.58 Cr
Sector: Diversified Indian Equities
Latest Official Announcement:Fortis Healthcare Q1 profit rises 2%; hospital revenue grows 19% on higher occupied beds - CNBC TV18
2mo ago
Plain-English Company Summary

FORTIS HEALTHCARE (FORTIS) is a Indian equity security listed on the NSE/BSE with ISIN BSE:532843. As of the last recorded market session on Close on 09 Oct 2026, the stock closed at ₹786.25, recording a +23.25 (+3.05%) advance from its previous close of ₹763.00. Over the trailing 52-week trading cycle, FORTIS has traded between a 52-week low of ₹763.00 and a 52-week high of ₹1097.90, establishing its annual trading channel. In historical performance, FORTIS HEALTHCARE has fallen 26.44% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +2.94%, 1-month: -14.07%, 6-month: -7.51%, 1-year: -26.44%, 3-year: +137.86%, 5-year: +193.38%. Daily reported trading volume reached 36,38,882 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 56.6x and a price-to-book (P/B) ratio of 6.0x, with a trailing dividend yield of 0.13%. Its market capitalization stands at ₹59,358.58 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.

Price Chart

1Y: -26.44% (₹-282.60)
₹1,098₹984₹874₹763Thu, 9 Oct, 2025Fri, 9 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Channel₹786.25
Low: ₹763High: ₹1,097.9
Day Range₹763 – ₹786.25
Market Cap₹59,358.58 Cr
Reported Volume36,38,882
P/E Ratio (TTM)56.6x
Price-to-Book (P/B)6.0x
Dividend Yield0.13%
Fundamentals as of 11 Oct 2026

Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)

How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).

1 Month Holding Period (21 trading days)
1,215 past 21-day periods analyzed
Fell 17%
Within ±5% (44.5%)
Rose 38.5%
Fell > 5%
17%
206 windows
Within ±5%
44.5%
541 windows
Rose > 5%
38.5%
468 windows
In 80% of past 1 month windows the move was within ±10.7%.
Historical outcomes of this stock's own price. Not a forecast. (1236 trading days of history).
How to read historical odds

How Outside Factors Affect This Stock (Market, Crude Oil & Currency)

How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.

Swing Rank: 50th percentile
Typical 1-Year Price Swing (Volatility): 27.0% annualized
Price Swing Level vs Market: Moderate Swings
Factor / Benchmark1Y Beta (Sensitivity)1Y Correlation (-1 to +1)What This Means
NIFTY 50+0.79+0.39Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +0.79% co-movement (correlation: 0.39). Descriptive historical relationship, not predictive.
USD / INR-0.38-0.10Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.38% co-movement (correlation: -0.10). Descriptive historical relationship, not predictive.
Brent Crude Oil-0.05-0.09Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.05% co-movement (correlation: -0.09). Descriptive historical relationship, not predictive.
US 10Y Treasury Yield-0.07-0.04Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.07% co-movement (correlation: -0.04). Descriptive historical relationship, not predictive.
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾

Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹763.80₹786.25+2.94%
15 Days₹877.35₹786.25-10.38%
1 Month₹915.00₹786.25-14.07%
3 Months₹951.45₹786.25-17.36%
6 Months₹850.05₹786.25-7.51%
1 Year₹1,068.85₹786.25-26.44%
3 Years₹330.55₹786.25+137.86%
5 Years₹268.00₹786.25+193.38%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
27.0%
Annualized volatility
1Y Beta vs Index
0.79
vs benchmark index
Biggest 1Y Drop
-30.5%
1Y peak-to-low drop
Biggest 5Y Drop
-30.5%
5Y peak-to-low drop
vs 52W High
-28.4%
Distance from 1Y high
vs 52W Low
+3.0%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹900.55₹786.25-12.7%
CY 2025₹708.50₹884.00+24.8%
CY 2024₹439.60₹719.85+63.8%
CY 2023₹281.95₹419.20+48.7%
CY 2022₹309.50₹286.10-7.6%
CY 2021₹268.00₹297.30+10.9%

Historical Investment Simulator

Factual simulation of past returns in FORTIS HEALTHCARE (FORTIS) using real recorded closing prices.

₹1,00,000.00
5 Years
Principal Invested
₹1,00,000.00
₹1,00,000.00 starting capital
Portfolio Value Today
₹2,93,376.87
Based on latest close
Absolute Return
+193.4%
+₹1,93,376.87
Annualized (CAGR)
+24.1%
Compound annual growth
Entry Price: ₹268.00 · Exit Price: ₹786.25
Simulated 5Y period (INR)

Corporate Actions & Distributions

Historical record of dividend payouts and share split adjustments for FORTIS.

Dividend Distributions (1)

Ex-DateDividend Amount
24 Jul 2026₹1.00 per share

Stock Splits & Multipliers (0)

No stock split adjustments recorded.

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 5 of 10 Updates
#1 EARNINGSLODR Materiality: 99/100Positive Business DriverBackground ContextDirect Mention
2mo ago

Fortis Healthcare Q1 profit rises 2%; hospital revenue grows 19% on higher occupied beds - CNBC TV18

Fortis Healthcare Q1 profit rises 2%; hospital revenue grows 19% on higher occupied beds CNBC TV18

Valuation Impact:+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Inspecting in Causal Panel
Source: CNBC TV18·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#2 EARNINGSLODR Materiality: 99/100Positive Business DriverBackground ContextDirect Mention
2mo ago

Fortis Healthcare Q1 net profit rises 2.3%; higher occupied beds, ARPOB drive growth - Moneycontrol.com

Fortis Healthcare Q1 net profit rises 2.3%; higher occupied beds, ARPOB drive growth Moneycontrol.com

Valuation Impact:+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Click to analyze
Source: Moneycontrol.com·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#3 EARNINGSLODR Materiality: 99/100Positive Business DriverBackground ContextDirect Mention
4mo ago

Fortis Healthcare Q4 profit up 45% on lower exceptional losses, higher revenue - CNBC TV18

Fortis Healthcare Q4 profit up 45% on lower exceptional losses, higher revenue CNBC TV18

Valuation Impact:+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Click to analyze
Source: CNBC TV18·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#4 EARNINGSLODR Materiality: 97/100Business HeadwindBackground ContextDirect Mention
2mo ago

Earnings Miss: Fortis Healthcare Limited Missed EPS By 7.1% And Analysts Are Revising Their Forecasts - Simply Wall Street

Earnings Miss: Fortis Healthcare Limited Missed EPS By 7.1% And Analysts Are Revising Their Forecasts Simply Wall Street

Valuation Impact:-2.5% to -6.0% (EBITDA Margin Compression Risk)
Click to analyze
Source: Simply Wall Street·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#5 CONTRACTS ORDERSLODR Materiality: 94/100Positive Business DriverOngoing ImpactDirect Mention
20d ago

Fortis Healthcare (NSE:FORTIS): What Did the Supreme Court Order on the Forensic Audit Mean? - Kalkine India

Fortis Healthcare (NSE:FORTIS): What Did the Supreme Court Order on the Forensic Audit Mean? Kalkine India

Valuation Impact:+2.5% to +5.5% (Order Backlog & Forward Revenue Accretion)
Click to analyze
Source: Kalkine India·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Event 1 of 5
Causal Attribution in Focus
EARNINGS·2mo ago
Verified Exchange / Wire Disclosure:
Fortis Healthcare Q1 profit rises 2%; hospital revenue grows 19% on higher occupied beds - CNBC TV18
Source: CNBC TV18·LODR Materiality: 99/100Tailwind
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Quarterly Financial Milestone & Operating Margins
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. FORTIS Accretion
+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Causal Attribution Analysis:Direct Named Awardee

Financial performance outpaced historical baseline, driving operating leverage and valuation re-rating.

Extracted Factual Evidence:
  • •Direct quantitative change registered at 2%
  • •Financial performance and operating margins expanded ahead of consensus projections
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.

Order Book & Revenue Visibility

Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.

Affected Financial Metrics:
Operating EBITDA MarginRevenue VisibilityNet Income (PAT)
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

At-a-Glance Health & Momentum Check

Market Mood: Expansionary / Momentum
News Activity
ACCELERATING
Recent announcement pace
Profit & Margin Trend
CONTRACTING
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Expansionary / Momentum
Current market trend
News Tone
POSITIVE EXPANSION
Recent filing tone
What This Means(based on reported financials)

While recent announcements reflect past operations, profit margins and return on capital have been tightening as the business absorbs higher costs or new expansion spending.

Active Risk Flags & Monitoring Constraints
Elevated regulatory and disclosure event clustering in observation windowPrice testing 52-week support threshold with elevated trading volume

Peer & Sector Comparison — Next Research Steps

Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.

Explore All Equities
Same-Sector Peers
Diversified Indian Equities
No direct peers in sector coverage.
Same-Industry Peers
Industry Sub-Segment
No peer equities in this industry.
Also Viewed In Session
Recent History
Start browsing to build your active session footprint.

Common Questions About FORTIS HEALTHCARE (FORTIS)

Key facts on FORTIS share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of FORTIS HEALTHCARE (FORTIS)?

As of 09 Oct 2026, the official closing share price of FORTIS HEALTHCARE (FORTIS) on NSE/BSE is ₹786.25 (+3.05% vs the previous close). Over the past 52 weeks, FORTIS has traded between a low of ₹763.00 and a high of ₹1,097.90, with a reported market capitalization of ₹59,358.58 Cr.

What are the historical returns of FORTIS HEALTHCARE (FORTIS)?

Based on split-adjusted closing prices through 09 Oct 2026, FORTIS HEALTHCARE (FORTIS) recorded the following trailing price returns: 1 Week: +2.94% (from ₹763.80 to ₹786.25); 15 Days: -10.38% (from ₹877.35 to ₹786.25); 1 Month: -14.07% (from ₹915.00 to ₹786.25); 3 Months: -17.36% (from ₹951.45 to ₹786.25); 6 Months: -7.51% (from ₹850.05 to ₹786.25); 1 Year: -26.44% (from ₹1,068.85 to ₹786.25); 3 Years: +137.86% (from ₹330.55 to ₹786.25); 5 Years: +193.38% (from ₹268.00 to ₹786.25). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of FORTIS HEALTHCARE (FORTIS)?

FORTIS HEALTHCARE (FORTIS) currently trades at a trailing Price-to-Earnings (P/E) ratio of 56.6x, a Price-to-Book (P/B) ratio of 6.0x, and a trailing 12-month dividend yield of 0.13%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).

How much would a past lump-sum or monthly SIP investment in FORTIS have grown?

Based on historical closing prices for FORTIS HEALTHCARE (FORTIS): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹2,93,376.87 (+193.4% total return, 24.1% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹6,10,000.00) would be worth ₹11,55,087.96 (+89.4% absolute return). You can test custom amounts and holding periods in the interactive calculator above.

Official Corporate Perspective

No authenticated statement registered for FORTIS.

Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.

Independent exchange feeds and algorithmic models cannot be edited or suppressed by corporate submissions.